Table 3. Applications of AI in COVID-19 progression.
| First author [year] (reference) | Country (region) | Modality | Model | Data source | Sample size | Result |
|---|---|---|---|---|---|---|
| Li et al. [2020] (51) | China | CT image | U-Net | COVID-19 patients in Shanghai Jiao Tong University Affiliated Sixth People’s Hospital from February 10, 2020 to April 9, 2020 | COVID-19 cases classified as non-severe group on admission: 123 | (CT-SS) AUC 0.66; accuracy 62.6%; sensitivity 58.97%; specificity: 64.29% (GGO volume cm3) AUC 0.639; accuracy 43.9%; sensitivity 79.49%; specificity: 45.24% (GGO volume percentage): AUC 0.694; accuracy 62.6%; sensitivity 64.1%; specificity: 69.05%; (consolidation volume cm3): AUC 0.796; accuracy 78.05%; sensitivity 71.79%; specificity: 80.95%; (consolidation volume percentage): AUC 0.79; accuracy 78.86%; sensitivity 79.49%; specificity: 78.57% |
| Yang et al. [2020] (52) | China | CT image | CT-SS | COVID-19 patients in Chongqing Three Gorges Central Hospital from January 21, 2020 to February 5, 2020 | COVID-19 cases: 102 | AUC: 0.892; sensitivity: 83.3%; specificity: 94% |
AI, artificial intelligence; COVID-19, coronavirus disease 2019; CT-SS, CT severity score; AUC, area under the curve; GGO, ground-glass opacity.